Search

everythinglearnresearchcommunity

for

Search:↓

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Hirsutism, excessive hair growth in women, is often caused by polycystic ovarian syndrome and is treated by targeting the cause, lifestyle changes, and medication.

Neurosteroids help control dopamine responses in the brain.

Certain gene variations may increase the risk of alopecia, and platelet-rich plasma treatment can improve hair density in those with hair loss; a rare case of facial Becker's nevus was linked to uneven beard growth.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

The document emphasizes the need for surgeons to stay updated with the latest hair restoration and removal techniques and introduces new, essential information in the field.

Drugs can change hair growth and this is important because it can upset people.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Dermal papilla cells play a key role in hair loss by responding to androgens.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Antiandrogen treatments can help with various women's health issues but often require ongoing use.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Androgen levels are more linked to body size in boys than girls.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

High levels of androgens can cause skin issues like acne, hair loss, and excessive hair growth.

Spironolactone effectively reduces symptoms of hyperandrogenism but has some side effects.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.